Primary CNS Lymphoma von Grommes, Christian, DeAngelis, Lisa M

Volltext

Primary central nervous system lymphoma von Schaff, Lauren R., Grommes, Christian

Volltext

Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma von Grommes, Christian, Rubenstein, James L, DeAngelis, Lisa M, Ferreri, Andres J M, Batchelor, Tracy T

Volltext

Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid von Pentsova, Elena I, Shah, Ronak H, Tang, Jiabin, Boire, Adrienne, You, Daoqi, Briggs, Samuel, Omuro, Antonio, Lin, Xuling, Fleisher, Martin, Grommes, Christian, Panageas, Katherine S, Meng, Fanli, Selcuklu, S Duygu, Ogilvie, Shahiba, Distefano, Natalie, Shagabayeva, Larisa, Rosenblum, Marc, DeAngelis, Lisa M, Viale, Agnes, Mellinghoff, Ingo K, Berger, Michael F

Volltext

Introduction of novel agents in the treatment of primary CNS lymphoma von Grommes, Christian, Nayak, Lakshmi, Tun, Han W, Batchelor, Tracy T

Volltext

R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma von Omuro, Antonio, Correa, Denise D., DeAngelis, Lisa M., Moskowitz, Craig H., Matasar, Matthew J., Kaley, Thomas J., Gavrilovic, Igor T., Nolan, Craig, Pentsova, Elena, Grommes, Christian C., Panageas, Katherine S., Baser, Raymond E., Faivre, Geraldine, Abrey, Lauren E., Sauter, Craig S.

Volltext

An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells von Rohle, Dan, Popovici-Muller, Janeta, Palaskas, Nicolaos, Turcan, Sevin, Grommes, Christian, Campos, Carl, Tsoi, Jennifer, Clark, Owen, Oldrini, Barbara, Komisopoulou, Evangelia, Kunii, Kaiko, Pedraza, Alicia, Schalm, Stefanie, Silverman, Lee, Miller, Alexandra, Wang, Fang, Yang, Hua, Chen, Yue, Kernytsky, Andrew, Rosenblum, Marc K., Liu, Wei, Biller, Scott A., Su, Shinsan M., Brennan, Cameron W., Chan, Timothy A., Graeber, Thomas G., Yen, Katharine E., Mellinghoff, Ingo K.

Volltext

Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma von Grommes, Christian, Tang, Sarah S., Wolfe, Julia, Kaley, Thomas J., Daras, Mariza, Pentsova, Elena I., Piotrowski, Anna F., Stone, Jacqueline, Lin, Andrew, Nolan, Craig P., Manne, Malbora, Codega, Paolo, Campos, Carl, Viale, Agnes, Thomas, Alissa A., Berger, Michael F., Hatzoglou, Vaios, Reiner, Anne S., Panageas, Katherine S., DeAngelis, Lisa M., Mellinghoff, Ingo K.

Volltext

Circulating Tumor DNA in the Blood: A New Frontier in Primary CNS Lymphoma? von Grommes, Christian

Volltext

Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (I... von Barajas, Ramon F, Politi, Letterio S, Anzalone, Nicoletta, Schöder, Heiko, Fox, Christopher P, Boxerman, Jerrold L, Kaufmann, Timothy J, Quarles, C Chad, Ellingson, Benjamin M, Auer, Dorothee, Andronesi, Ovidiu C, Ferreri, Andres J M, Mrugala, Maciej M, Grommes, Christian, Neuwelt, Edward A, Ambady, Prakash, Rubenstein, James L, Illerhaus, Gerald, Nagane, Motoo, Batchelor, Tracy T, Hu, Leland S

Volltext

Molecular and Clinical Effects of Notch Inhibition in Glioma Patients: A Phase 0/I Trial von Xu, Ran, Shimizu, Fumiko, Hovinga, Koos, Beal, Kathryn, Karimi, Sasan, Droms, Leif, Peck, Kyung K, Gutin, Philip, Iorgulescu, J Bryan, Kaley, Thomas, DeAngelis, Lisa, Pentsova, Elena, Nolan, Craig, Grommes, Christian, Chan, Timothy, Bobrow, Dylan, Hormigo, Adilia, Cross, Justin R, Wu, Nian, Takebe, Naoko, Panageas, Katherine, Ivy, Percy, Supko, Jeffrey G, Tabar, Viviane, Omuro, Antonio

Volltext

Retrospective review of safety and efficacy of programmed cell death-1 inhibitors in refractory high grade gliomas von Reiss, Samantha N, Yerram, Prakirthi, Modelevsky, Lisa, Grommes, Christian

Volltext

Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma von Omuro, Antonio, Beal, Kathryn, Gutin, Philip, Karimi, Sasan, Correa, Denise D, Kaley, Thomas J, DeAngelis, Lisa M, Chan, Timothy A, Gavrilovic, Igor T, Nolan, Craig, Hormigo, Adilia, Lassman, Andrew B, Mellinghoff, Ingo, Grommes, Christian, Reiner, Anne S, Panageas, Katherine S, Baser, Raymond E, Tabar, Viviane, Pentsova, Elena, Sanchez, Juan, Barradas-Panchal, Renata, Zhang, Jianan, Faivre, Geraldine, Brennan, Cameron W, Abrey, Lauren E, Huse, Jason T

Volltext

Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I study von Schaff, Lauren R, Lobbous, Mina, Carlow, Dean, Schofield, Ryan, Gavrilovic, Igor T, Miller, Alexandra M, Stone, Jacqueline B, Piotrowski, Anna F, Sener, Ugur, Skakodub, Anna, Acosta, Edward P, Ryan, Kevin J, Mellinghoff, Ingo K, DeAngelis, Lisa M, Nabors, Louis B, Grommes, Christian

Volltext

Ibrutinib in PCNSL: The Curious Cases of Clinical Responses and Aspergillosis von Grommes, Christian, Younes, Anas

Volltext

Long-term survival and cognitive function follow up of primary CNS lymphoma treated with R-MVP followed by high dose chemotherapy with autologous stem cell transplant consolidation... von Therkelsen, Kate, Grommes, Christian

Volltext

EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer von Oldrini, Barbara, Hsieh, Wan-Ying, Erdjument-Bromage, Hediye, Codega, Paolo, Carro, Maria Stella, Curiel-García, Alvaro, Campos, Carl, Pourmaleki, Maryam, Grommes, Christian, Vivanco, Igor, Rohle, Daniel, Bielski, Craig M., Taylor, Barry S., Hollmann, Travis J., Rosenblum, Marc, Tempst, Paul, Blenis, John, Squatrito, Massimo, Mellinghoff, Ingo K.

Volltext

NCOG-36. LONG-TERM SURVIVAL AND COGNITIVE FUNCTION FOLLOW UP OF PRIMARY CNS LYMPHOMA TREATED WITH R-MVP FOLLOWED BY HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANT CONS... von Therkelsen, Kate, Grommes, Christian

Volltext

Phase I Study of Single Agent Ibrutinib in Recurrent/Refractory Primary and Secondary CNS Lymphoma von Christian, Grommes, Thomas, Kaley, Abdel-Wahab, Omar, Omuro, Antonio M., Ingo, Mellinghoff, DeAngelis, Lisa

Volltext

Abstract LB-302: Potential role of larotrectinib (LOXO-101), a selective pan-TRK inhibitor, in NTRK fusion-positive recurrent glioblastoma von Schram, Alison M., Taylor, Barry S., Hechtman, Jaclyn F., Benayed, Ryma, Wang, Lu, Hanusch, Bethany, Young, Robert, Grommes, Christian, Ku, Nora, Hyman, David M., Kaley, Thomas, Drilon, Alexander

Volltext